The author Announces the Publication of its Procurement Research Report – Global Drug Intermediates and APIs Category - Procurement Market Intelligence Report 2019-2024.
The author recognizes the following companies as the key suppliers in the Global Drug Intermediates and APIs Category - Procurement Market Intelligence Report: Pfizer Inc, Merck & Co. Inc, Sanofi, Boehringer Ingelheim International GmbH, Novartis AG, Evonik Industries AG.
Commenting on the report, an analyst from the author said: “One of the procurement best practices for buyers is to adopt big data analytics in the procurement process to gain benefits such as demand projection, insights into pricing trends of APIs and intermediates from historical data, among others.”
According to the report, one of the key growth contributors for the global drug intermediates and APIs market is the increasing demand from the pharmaceutical companies that are one of the key end-users.
Further, the report states that one of the key category management strategies for the buyers in the global drug intermediates and APIs market is to engage with suppliers who can ensure supply assurance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
The author recognizes the following companies as the key suppliers in the Global Drug Intermediates and APIs Category - Procurement Market Intelligence Report: Pfizer Inc, Merck & Co. Inc, Sanofi, Boehringer Ingelheim International GmbH, Novartis AG, Evonik Industries AG.
Commenting on the report, an analyst from the author said: “One of the procurement best practices for buyers is to adopt big data analytics in the procurement process to gain benefits such as demand projection, insights into pricing trends of APIs and intermediates from historical data, among others.”
According to the report, one of the key growth contributors for the global drug intermediates and APIs market is the increasing demand from the pharmaceutical companies that are one of the key end-users.
Further, the report states that one of the key category management strategies for the buyers in the global drug intermediates and APIs market is to engage with suppliers who can ensure supply assurance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: MARKET INSIGHTS
PART 03: CATEGORY PRICING INSIGHTS
PART 04: COST-SAVING OPPORTUNITIES
PART 05: BEST PRACTICES
PART 06: CATEGORY ECOSYSTEM
PART 07: CATEGORY MANAGEMENT STRATEGY
PART 08: CATEGORY MANAGEMENT ENABLERS
PART 09: SUPPLIERS SELECTION
PART 10: SUPPLIERS UNDER COVERAGE
PART 11: US MARKET INSIGHTS
PART 12: CATEGORY DEFINITION
PART 13: APPENDIX
Companies Mentioned
- Pfizer Inc
- Merck & Co. Inc
- Sanofi
- Boehringer Ingelheim International GmbH
- Novartis AG
- Evonik Industries AG
Methodology
LOADING...